Talicia Frequently Asked Questions
Talicia is for the treatment of Helicobater pylori infection in adults.
Talicia is a unique combination of omeprazole magnesium (10.3 mg), amoxicillin (250 mg), and rifabutin (12.5 mg) in all-in-one capsules.
Talicia is the only treatment that combines two antibiotics and a proton-pump inhibitor into all-in-one capsules. Talicia is a unique all-in-one combination of omeprazole magnesium (10.3 mg), amoxicillin (250 mg), and rifabutin (12.5 mg). In the Talicia pivotal trial, zero-to-minimal H. pylori resistance was seen to the antibiotics in Talicia.1
Talicia is well tolerated. Only 1% of patients discontinued therapy due to side effects. The most common side effects experienced by 1% or more of patients taking Talicia were diarrhea, headache, nausea, stomach pain, rash, indigestion, mouth or throat pain, vomiting, vaginal yeast infection, and a brown-orange discoloration of the urine, sweat or skin, which goes away after therapy is completed or discontinued.
Savings and Coverage Frequently Asked Questions
Eligible, commercially insured patients may pay as little as $35 per prescription fill of Talicia. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs.
REFERENCE: 1. Graham DY, Canaan Y, Maher J, Wiener G, Hulten KG, Kalfus IN. Rifabutin-based triple therapy (RHB-105) for Helicobacter pylori eradication: a double-blind, randomized, controlled trial. Ann Intern Med. 2020;172(12):795-802.